Navigation Links
Injectable sponge delivers drugs, cells, and structure
Date:11/13/2012

Cambridge, Mass. November 13, 2012 Bioengineers at Harvard have developed a gel-based sponge that can be molded to any shape, loaded with drugs or stem cells, compressed to a fraction of its size, and delivered via injection. Once inside the body, it pops back to its original shape and gradually releases its cargo, before safely degrading.

The biocompatible technology, revealed this week in the Proceedings of the National Academy of Sciences, amounts to a prefabricated healing kit for a range of minimally invasive therapeutic applications, including regenerative medicine.

"What we've created is a three-dimensional structure that you could use to influence the cells in the tissue surrounding it and perhaps promote tissue formation," explains principal investigator David J. Mooney, Robert P. Pinkas Family Professor of Bioengineering at the Harvard School of Engineering and Applied Sciences (SEAS) and a Core Faculty Member at the Wyss Institute for Biologically Inspired Engineering at Harvard.

"The simplest application is when you want bulking," Mooney explains. "If you want to introduce some material into the body to replace tissue that's been lost or that is deficient, this would be ideal. In other situations, you could use it to transplant stem cells if you're trying to promote tissue regeneration, or you might want to transplant immune cells, if you're looking at immunotherapy."

Consisting primarily of alginate, a seaweed-based jelly, the injectable sponge contains networks of large pores, which allow liquids and large molecules to easily flow through it. Mooney and his research team demonstrated that live cells can be attached to the walls of this network and delivered intact along with the sponge, through a small-bore needle. Mooney's team also demonstrated that the sponge can hold large and small proteins and drugs within the alginate jelly itself, which are gradually released as the biocompatible matrix starts to break down inside the body.

Normally, a scaffold like this would have to be implanted surgically. Gels can also be injected, but until now those gels would not have carried any inherent structure; they would simply flow to fill whatever space was available.

"Our scaffolds can be designed in any size and shape, and injected in situ as a safe, preformed, fully characterized, sterile, and controlled delivery device for cells and drugs," says lead author Sidi Bencherif, a postdoctoral research associate in Mooney's lab at SEAS and at the Wyss Institute.

Bencherif and his colleagues pushed pink squares, hearts, and stars through a syringe to demonstrate the versatility and robustness of their gel.

The spongelike gel is formed through a freezing process called cryogelation. As the water in the alginate solution starts to freeze, pure ice crystals form, which makes the surrounding gel more concentrated as it sets. Later on, the ice crystals melt, leaving behind a network of pores. By carefully calibrating this mixture and the timing of the freezing process, Mooney, Bencherif, and their colleagues found that they could produce a gel that is extremely strong and compressible, unlike most alginate gels, which are brittle.

The resulting "cryogel" fills a gap that has previously been unmet in biomedical engineering.

"These injectable cryogels will be especially useful for a number of clinical applications including cell therapy, tissue engineering, dermal filler in cosmetics, drug delivery, and scaffold-based immunotherapy," says Bencherif. "Furthermore, the ability of these materials to reassume specific, pre-defined shapes after injection is likely to be useful in applications such as tissue patches where one desires a patch of a specific size and shape, and when one desires to fill a large defect site with multiple smaller objects. These could pack in such a manner to leave voids that enhance diffusional transport to and from the objects and the host, and promote vascularization around each object."

The next step in the team's research is to perfect the degradation rate of the scaffold so that it breaks down at the same rate at which newly grown tissue replaces it. Harvard's Office of Technology Development has filed patent applications on the invention and is actively pursuing licensing and commercialization opportunities.


'/>"/>

Contact: Caroline Perry
cperry@seas.harvard.edu
617-496-1351
Harvard University
Source:Eurekalert  

Related medicine news :

1. Under-twisted DNA origami delivers cancer drugs to tumors
2. Adena Delivers Instant Health Information to Mobile Devices
3. A Revolutionary Dietary Paradigm: New Cookbook Features A SOS-free (Salt, Oil, Sugar ) Diet That Delivers the Optimal Food Plan for Renewing Health
4. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
5. New drugs, new ways to target androgens in prostate cancer therapy
6. Cancer turns off important immune cells, complicating experimental vaccine therapies
7. Helper T cells, not killer T cells, might be responsible for clearing hepatitis A infection
8. Glucose deprivation activates feedback loop that kills cancer cells, UCLA study shows
9. New candidate drug stops cancer cells, regenerates nerve cells
10. Cedars-Sinai researchers, with stem cells, advance understanding of spinal muscular atrophy
11. Black Belts Punching Power Linked to Their Brain Structure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Injectable sponge delivers drugs, cells, and structure
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/27/2016)... Wis. (PRWEB) , ... May 27, 2016 , ... ... $90,000 in scholarships to students studying complementary medicine. Allison Outerbridge is this year’s ... accepted her award on May 18 at the university’s Student Leadership Awards ceremony. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports ... Yellen and company to wait until March 2017 for an interest rate increase, according ... Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts are ...
(Date:5/26/2016)... ... 2016 , ... W.S. Badger Co. Inc ., the maker of certified ... Work Works Award for its use of effective workplace strategies to increase business and ... administered by the Families and Work Institute (FWI) and the Society for Human Resource ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the healthcare industry leader ... its inaugural Member Conference at the Paris Hotel in Las Vegas, Nev., May ... of America’s healthcare providers. , The conference was highlighted by the announcement of ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 MedDay, ... disorders, announces that an oral presentation entitled "High doses of ... MS-SPI trial" will be given by Professor Ayman Tourbah ... 2nd Congress of the European Academy of Neurology (EAN) in ... and related disorders 3" will take place on Sunday, 29 ...
(Date:5/24/2016)... , May 24, 2016 ... Markt gebracht, die es Ärzten erlaubt, ihre Expertise ... behandeln: MDLinking kombiniert Live Streaming mit einer Instant-Messaging-Funktion ... zu kommunizieren. Mediziner in Europa, Afrika, Asien und ... bereits für die Plattform registriert. Information ...
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
Breaking Medicine Technology: